Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res. 2010; 12(6):R102.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.